Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Programmed Death-1 & Programmed Death Ligand-1 Inhibitors Market Analysis, Size and Growth, 2025

Author: David Lee
by David Lee
Posted: Dec 13, 2017

The global programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors market is valued at an estimated $4,926.4 million in 2016, and it is expected to grow at a CAGR of 23.4% during 2017 - 2025. The growth of the global market is largely driven by the increased investment and funding, strong pipeline, and improved safety and efficacy.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/pd1-and-pdl1-inhibitors-market

Some of the other factors driving the growth of the global market include technological advancements and innovations, and high prevalence of cancer. Less number of competitors and expected launch of Phase III drug candidates will create ample growth opportunities for the global market. However, high cost of research and therapy, and stringent and time consuming regulatory process are the key barriers for the growth of the global market.

PD-1 and PD-L1 inhibitors are highly growing immunotherapies that are being used in oncology therapy area. The pipeline of PD-1 and PD-L1 inhibitors is enriched with 47 drugs and there are approximately 245 active clinical studies. There are many drugs in early stage of pipeline; thus, making PD1 and PDL1 inhibitors market very lucrative.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/pd1-and-pdl1-inhibitors-market/report-sample

Among the two mechanisms of action, the PD-1 inhibitors were estimated to contribute 97.2% to the global PD-1 and PD-L1 inhibitors market in 2016. However, the approval of Tecentriq and expected approval of durvalumab and avelumab during forecast period will significantly increase PD-L1 inhibitors revenue contribution to the global market.

Some of the key players operating in the global market include Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc and others.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

About the Author

Contact: P&S Intelligence Toll-free: +1-888-778-7886 (USA/Canada) International: +1-347-960-6455 Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: David Lee

David Lee

Member since: Aug 30, 2017
Published articles: 129

Related Articles